Ticker Details
Amphastar Pharmaceuticals, Inc. Amphastar Pharmaceuticals Inc is a specialty pharmaceutical company engaged in developing, manufacturing, marketing and selling generic and proprietary injectable & inhalation products. Its products are used in hospitals or urgent care clinical settings.
IPO Date:	June 25, 2014
Sector:	Healthcare
Industry:	Drug Manufacturers
Market Cap:	$1.31B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.41 | 1.68%
Avg Daily Range (30 D):	$0.45 | 1.62%
Avg Daily Range (90 D):	$0.49 | 1.84%

Institutional Daily Volume
Avg Daily Volume:	.25M
Avg Daily Volume (30 D):	.26M
Avg Daily Volume (90 D):	.29M

Trade Size
Avg Trade Size (Sh.):	64
Avg Trade Size (Sh.) (30 D):	40
Avg Trade Size (Sh.) (90 D):	40

Institutional Trades
Total Institutional Trades:	2,504
Avg Institutional Trade:	$1.78M
Avg Institutional Trade (30 D):	$1.3M
Avg Institutional Trade (90 D):	$1.46M
Avg Institutional Trade Volume:	.06M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$2.05M
Avg Closing Trade (30 D):	$1.42M
Avg Closing Trade (90 D):	$1.54M
Avg Closing Volume:	68.56K

News

Oct 9, 2025 @ 1:31 PM Teva, Viatris On Investor Watch As White House Spa... Source: Vandana Singh

Jun 5, 2025 @ 5:00 PM Global Antidote Market to Cross the USD 4 Billion ... Source: Delveinsight

Sep 6, 2024 @ 5:46 PM JP Morgan Shows Most Interest In Teva, Organon As ... Source: Vandana Singh

Jul 23, 2024 @ 5:01 PM HCA Healthcare (HCA) Beats on Q2 Earnings, Ups 202... Source: N/A

May 30, 2024 @ 6:06 AM Amphastar Pharmaceuticals: Buy When Fear Is Overbl... Source: James Long

Financials
	TTM	Q3 2025	Q2 2025
Basic EPS		$.38	$.66
Diluted EPS		$.37	$.64
Revenue		$191.84M	$174.41M
Gross Profit		$98.65M	$86.49M
Net Income / Loss		$17.35M	$31.03M
Operating Income / Loss		$25.32M	$42.18M
Cost of Revenue		$93.19M	$87.92M
Net Cash Flow		$28.58M	$4.91M
PE Ratio